JP2017537925A5 - - Google Patents

Info

Publication number

JP2017537925A5

JP2017537925A5 JP2017529746A JP2017529746A JP2017537925A5 JP 2017537925 A5 JP2017537925 A5 JP 2017537925A5 JP 2017529746 A JP2017529746 A JP 2017529746A JP 2017529746 A JP2017529746 A JP 2017529746A JP 2017537925 A5 JP2017537925 A5 JP 2017537925A5

Authority

JP

Japan

Prior art keywords

seq

amino acid

acid sequence

chain variable

variable region

Prior art date

2015-12-04

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 150000001413 amino acids Chemical class 0.000 claims description 326
• 125000003275 alpha amino acid group Chemical group 0.000 claims description 260
• 238000012986 modification Methods 0.000 claims description 225
• 230000004048 modification Effects 0.000 claims description 210
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 133
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 80
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 77
• 229920001184 polypeptide Polymers 0.000 claims description 76
• -1 amino Chemical group 0.000 claims description 47
• 210000004027 cell Anatomy 0.000 claims description 39
• 206010028980 Neoplasm Diseases 0.000 claims description 34
• 239000000427 antigen Substances 0.000 claims description 30
• 102000036639 antigens Human genes 0.000 claims description 30
• 108091007433 antigens Proteins 0.000 claims description 30
• 150000007523 nucleic acids Chemical class 0.000 claims description 30
• 108020004707 nucleic acids Proteins 0.000 claims description 28
• 102000039446 nucleic acids Human genes 0.000 claims description 28
• 230000009826 neoplastic cell growth Effects 0.000 claims description 19
• 208000034578 Multiple myelomas Diseases 0.000 claims description 16
• 206010035226 Plasma cell myeloma Diseases 0.000 claims description 16
• 230000000139 costimulatory effect Effects 0.000 claims description 15
• 230000011664 signaling Effects 0.000 claims description 15
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 14
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 14
• 230000003834 intracellular effect Effects 0.000 claims description 12
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 10
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 8
• 208000017604 Hodgkin disease Diseases 0.000 claims description 8
• 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 8
• 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 8
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 8
• 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims description 8
• 208000005017 glioblastoma Diseases 0.000 claims description 8
• 239000008194 pharmaceutical composition Substances 0.000 claims description 8
• 208000016025 Waldenstroem macroglobulinemia Diseases 0.000 claims description 7
• 102000004127 Cytokines Human genes 0.000 claims description 6
• 108090000695 Cytokines Proteins 0.000 claims description 6
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 claims description 6
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 claims description 6
• 210000003719 b-lymphocyte Anatomy 0.000 claims description 6
• 239000003446 ligand Substances 0.000 claims description 6
• 230000028993 immune response Effects 0.000 claims description 5
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 4
• 108010021064 CTLA-4 Antigen Proteins 0.000 claims description 4
• 102000008203 CTLA-4 Antigen Human genes 0.000 claims description 4
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 4
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 4
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims description 4
• 210000001778 pluripotent stem cell Anatomy 0.000 claims description 4
• 102000004169 proteins and genes Human genes 0.000 claims description 4
• 108090000623 proteins and genes Proteins 0.000 claims description 4
• 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 3
• 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 3
• 230000004083 survival effect Effects 0.000 claims description 3
• 210000004881 tumor cell Anatomy 0.000 claims description 3
• 108010082808 4-1BB Ligand Proteins 0.000 claims description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 2
• 102100036008 CD48 antigen Human genes 0.000 claims description 2
• 102100025221 CD70 antigen Human genes 0.000 claims description 2
• 101000716130 Homo sapiens CD48 antigen Proteins 0.000 claims description 2
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 2
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 2
• 101000648507 Homo sapiens Tumor necrosis factor receptor superfamily member 14 Proteins 0.000 claims description 2
• 108090000177 Interleukin-11 Proteins 0.000 claims description 2
• 108010065805 Interleukin-12 Proteins 0.000 claims description 2
• 108090000172 Interleukin-15 Proteins 0.000 claims description 2
• 108050003558 Interleukin-17 Proteins 0.000 claims description 2
• 108010002350 Interleukin-2 Proteins 0.000 claims description 2
• 108010002386 Interleukin-3 Proteins 0.000 claims description 2
• 108090001005 Interleukin-6 Proteins 0.000 claims description 2
• 108010002586 Interleukin-7 Proteins 0.000 claims description 2
• 102000017578 LAG3 Human genes 0.000 claims description 2
• 101150030213 Lag3 gene Proteins 0.000 claims description 2
• 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
• 108010042215 OX40 Ligand Proteins 0.000 claims description 2
• 108010076504 Protein Sorting Signals Proteins 0.000 claims description 2
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 2
• 102100026890 Tumor necrosis factor ligand superfamily member 4 Human genes 0.000 claims description 2
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 claims description 2
• 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims description 2
• 210000001671 embryonic stem cell Anatomy 0.000 claims description 2
• 239000012634 fragment Substances 0.000 claims description 2
• 108010074108 interleukin-21 Proteins 0.000 claims description 2
• 210000004698 lymphocyte Anatomy 0.000 claims description 2
• 210000003738 lymphoid progenitor cell Anatomy 0.000 claims description 2
• 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
• 210000003289 regulatory T cell Anatomy 0.000 claims description 2
• 210000000130 stem cell Anatomy 0.000 claims description 2
• 239000002253 acid Substances 0.000 claims 46
• 230000008859 change Effects 0.000 claims 14
• 239000000203 mixture Substances 0.000 claims 7
• 208000035269 cancer or benign tumor Diseases 0.000 claims 4
• 101100510617 Caenorhabditis elegans sel-8 gene Proteins 0.000 claims 1
• 230000003796 beauty Effects 0.000 claims 1
• 238000004519 manufacturing process Methods 0.000 claims 1
• 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
• 238000000034 method Methods 0.000 description 17
• 230000019491 signal transduction Effects 0.000 description 2
• BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 108020003175 receptors Proteins 0.000 description 1
• 102000005962 receptors Human genes 0.000 description 1